Market Research - STAAR Surgical’s Collamer(R) IOL Designated as a New Technology

STAAR Surgical’s Collamer(R) IOL Designated as a New Technology
Forbes - ASCs perform well over one half of all cataract surgeries in the U.S. according to Market Scope, a leading market research provider for the ophthalmic market.

From the Cubefiles Marketing Dept.

Comments are closed